These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 26264674

  • 1. Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.
    Scott A, Baidya S, Butler J, Morris K, Thornton A, Kennedy GA.
    Transfusion; 2016 Jan; 56(1):164-9. PubMed ID: 26264674
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
    Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, Van Besien K.
    Bone Marrow Transplant; 2014 May; 49(5):722-4. PubMed ID: 24535131
    [No Abstract] [Full Text] [Related]

  • 4. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
    Nakazawa Y, Saito S, Hasegawa Y, Yanagisawa R, Sakashita K, Kamijo T, Miyazaki T, Sato S, Ikeda H, Ikebuchi K, Koike K.
    Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.
    Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.
    Fu Q, Xu L, Zhang X, Wang Y, Chang Y, Liu K, Huang X.
    Sci China Life Sci; 2018 May 01; 61(5):569-577. PubMed ID: 28914433
    [Abstract] [Full Text] [Related]

  • 13. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases.
    Pai SC, Lo SC, Lin Tsai SJ, Chang JS, Lin DT, Lin KS, Lin LI.
    Transfusion; 2010 Nov 15; 50(11):2318-27. PubMed ID: 20497513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.
    Delia M, Pastore D, Mestice A, Carluccio P, Perrone T, Gaudio F, Ricco A, Sgherza N, Albano F, Specchia G.
    Biol Blood Marrow Transplant; 2013 Mar 15; 19(3):495-9. PubMed ID: 23200706
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.